Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Economic Cost and Sustainability of Oral Therapies in Precision Oncology.
Desai AP, Scheckel CJ, Soderberg LC, Jensen CJ, Orme JJ, Tella SH, Kommalapati A, Pritchett JC, Khera N, Mahipal A, Go RS; Mayo Clinic Hematology and ONcology Outcomes Research (HONOR) Group. Desai AP, et al. Among authors: jensen cj. JCO Oncol Pract. 2022 Aug;18(8):e1247-e1254. doi: 10.1200/OP.21.00847. Epub 2022 May 26. JCO Oncol Pract. 2022. PMID: 35617640
Implementing and Optimizing Biosimilar Use at Mayo Clinic.
Jensen CJ, Tichy EM, Lempke MB, Ewald AM, Erickson SJ, Holm MR, Soefje SA. Jensen CJ, et al. Mayo Clin Proc. 2022 Jun;97(6):1086-1093. doi: 10.1016/j.mayocp.2022.02.015. Epub 2022 Mar 22. Mayo Clin Proc. 2022. PMID: 35337661
Multiple Myeloma: Current Clinical Landscape and Compounding Costs.
Beck K, Sandahl T, Ailawadhi S, Khera N, Jensen C. Beck K, et al. Among authors: jensen c. Curr Hematol Malig Rep. 2023 Oct;18(5):201-215. doi: 10.1007/s11899-023-00705-8. Epub 2023 Jul 21. Curr Hematol Malig Rep. 2023. PMID: 37477783 Review.
Neulasta Onpro: a coup de grâce?
Jensen CJ, Scheckel CJ, Go RS, Desai A, Soefje SA. Jensen CJ, et al. Am J Manag Care. 2023 Mar 1;29(3):e69-e70. doi: 10.37765/ajmc.2023.89331. Am J Manag Care. 2023. PMID: 36947018 Free article.
Non-neutralizing antibodies and limitations of serologic testing for severe acute respiratory syndrome coronavirus 2 in patients receiving immunoglobulin replacement products.
Manian DV, Jensen C, Theel ES, Mills JR, Joshi A. Manian DV, et al. Among authors: jensen c. Ann Allergy Asthma Immunol. 2021 Feb;126(2):206-207. doi: 10.1016/j.anai.2020.11.009. Epub 2020 Nov 21. Ann Allergy Asthma Immunol. 2021. PMID: 33232829 Free PMC article. No abstract available.
2,151 results